DUBLIN, Mar. 23, 2015 /PRNewswire/ --Research and Markets
(http://www.researchandmarkets.com/research/t9xv29/implantable) has announced the addition of the "Implantable Infusion Pumps: World Market Analysis" report to their offering.
Implantable infusion pumps are intended to provide long-term continuous or intermittent drug infusion; possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, and epidural. They are the least utilized and most complex of infusion pumps. These pumps are typically labeled for specific drugs, dosages, and routes of administration and require a high level of sophistication in the technology to run these pumps. For this reason, there are few pumps approved by regulatory agencies around the world and unit costs for these pumps remain high.
Implantable infusion pumps are most commonly used to administer:
- Chemotherapy for liver cancer patients
- Anti-spasmodic drugs for those with severe spasticity
- Opioid drugs for treatment of chronic intractable pain
Implantable Infusion Pumps: World Market Analysis analyzes the current and potential world market for implantable infusion pumps, with market forecasts to 2018.
The report includes discussion of:
- Key products, manufacturers and recent developments, including MRI compatibility
- Safety issues
- Market summary
The companies discussed in the report are:
- Medtronic
- Flowonix Medical, Inc.
- Codman & Shurtleff
- I-Flow / Halyard Health
For more information visit http://www.researchandmarkets.com/research/t9xv29/implantable
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
